Hector Group Joins ‘Oncotect Consortium’… Developing AI Medical Device for Lung Cancer Diagnosis and Recurrence Prediction

조선일보

Lean Right

Factuality

Ownership

Hecto Group is embarking on the development of artificial intelligence (AI) medical devices that support the early diagnosis and recurrence prediction of lung cancer. On the 1st, Hecto Group announced that its dedicated AI organization, ‘HAI (Hecto AI)’ headquarters, is participating in the ‘OnKoTECT Consortium’ centered on Seoul National University Bundang Hospital to develop AI-based software medical devices while carrying out a national proje…